Panacea Biotec Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹165.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.05 per cent from ₹141.13 crore. This corresponds to a year-on-year *(YoY) growth of 1.04 per cent.
Operating Profit
Operating Profit stands at ₹11.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 165.99 per cent from ₹-17.79 crore. This corresponds to a year-on-year *(YoY) growth of 47.49 per cent.
PBDT
PBDT stands at ₹14.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 237.95 per cent from ₹-10.83 crore. This corresponds to a year-on-year *(YoY) growth of 11.83 per cent.
Profit Before Tax
Profit Before Tax stands at ₹6.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 133.85 per cent from ₹-19.17 crore. This corresponds to a year-on-year *(YoY) growth of 48.17 per cent.
Net Profit
Net Profit stands at ₹3.89 crore, reflecting a quarter-on-quarter *(QoQ) increase of 127.77 per cent from ₹-14.01 crore. This represents a 12.39 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Panacea Biotec Ltd Earnings
- YOY
- QOQ
Panacea Biotec Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Panacea Biotec Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Panacea Biotec Ltd Financial Reports
Panacea Biotec Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Panacea Biotec | -1.11% | 0.72% | 13.39% | 24.72% | 12.16% | -22.52% |
| Dishman Carbogen | -7.37% | 3.66% | 11.69% | 5.65% | -20.04% | -27.61% |
| Gufic BioScience | 0.88% | 2.81% | 0.02% | 3.35% | -20.47% | -22.94% |
| Unichem Labs. | 0.07% | -0.08% | -1.27% | 5.47% | -20.72% | -39.04% |
| Hikal | 0.02% | 0.29% | 8.27% | 1.46% | -7.34% | -45.89% |
| Morepen Labs. | -0.33% | 2.53% | -0.65% | -4.03% | -3.27% | -35.63% |
| Kwality Pharma | 2.21% | 6.83% | 33.64% | 45.79% | 135.10% | 124.71% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Rajesh Jain
ED / Joint MD / Promoter : Sandeep Jain
WTD & Executive Director : Ankesh Jain
WTD & Executive Director : Harshet Jain
Executive Director / WTD - Technical : Sanjay Trehan
Independent Non Exe. Director : Ambika Sharma
Independent Non Exe. Director : Krishan Kumar Jalan
Independent Non Exe. Director : Rajesh Jain
Independent Non Exe. Director : Rajender Pal Singh
Independent Non Exe. Director : Venkatesh Sarvasiddhi
CS / Compliance Officer / Group CFO / Head - Legal : Vinod Goel